Retrieve available abstracts of 14 articles: HTML format
Single Articles
June 2025
SHEN J, Kharitonova E, Tytula A, Zawieja J, et al Vaccination strategies, public health impact and cost-effectiveness of dengue
vaccine TAK-003: A modeling case study in Thailand.
PLoS Med. 2025;22:e1004631. PubMedAbstract available
April 2025
Correction: Contraception use and pregnancy in women receiving a 2-dose Ebola
vaccine in Rwanda: A retrospective analysis of UMURINZI vaccination campaign
data.
PLoS Med. 2025;22:e1004605. PubMedAbstract available
February 2025
GENG L, Whittles LK, Dickens BL, Chio MTW, et al Potential public health impacts of gonorrhea vaccination programmes under
declining incidences: A modeling study.
PLoS Med. 2025;22:e1004521. PubMedAbstract available
INGABIRE R, Nyombayire J, Mazzei A, Mazarati JB, et al Contraception use and pregnancy in women receiving a 2-dose Ebola vaccine in
Rwanda: A retrospective analysis of UMURINZI vaccination campaign data.
PLoS Med. 2025;22:e1004508. PubMedAbstract available
GRAIS RF, Neuzil KM, Rees H, Toscano CM, et al Protecting mother and baby: Learnings from an Ebola vaccination campaign on the
evolving landscape of vaccines and pregnancy.
PLoS Med. 2025;22:e1004530. PubMedAbstract available
GUTTIERES D, Diepvens C, Grais RF, Kiarie J, et al Charting a novel path towards Ebola virus disease preparedness: Considerations
for preventive vaccination.
PLoS Med. 2025;22:e1004543. PubMedAbstract available
January 2025
SEIDLEIN LV Roll out and prospects of the malaria vaccine R21/Matrix-M.
PLoS Med. 2025;22:e1004515. PubMedAbstract available
GENG L, Whittles LK, Dickens BL, Chio MTW, et al Correction: Potential public health impacts of gonorrhea vaccination programmes
under declining incidences: A modeling study.
PLoS Med. 2025;22:e1004573. PubMedAbstract available
October 2024
MUNDAY JD, Atkins KE, Klinkenberg D, Meurs M, et al Estimating the risk and spatial spread of measles in populations with high MMR
uptake: Using school-household networks to understand the 2013 to 2014 outbreak
in the Netherlands.
PLoS Med. 2024;21:e1004466. PubMedAbstract available
September 2024
INIZAN C, Courtot A, Sturmach C, Griffon AF, et al Levels and functionality of Pacific Islanders' hybrid humoral immune response to
BNT162b2 vaccination and delta/omicron infection: A cohort study in New
Caledonia.
PLoS Med. 2024;21:e1004397. PubMedAbstract available
June 2024
PEREZ CHACON G, Estcourt MJ, Totterdell J, Marsh JA, et al Immunogenicity, reactogenicity, and IgE-mediated immune responses of a mixed
whole-cell and acellular pertussis vaccine schedule in Australian infants: A
randomised, double-blind, noninferiority trial.
PLoS Med. 2024;21:e1004414. PubMedAbstract available
LEACH AJ, Wilson N, Arrowsmith B, Beissbarth J, et al Hearing loss in Australian First Nations children at 6-monthly assessments from
age 12 to 36 months: Secondary outcomes from randomised controlled trials of
novel pneumococcal conjugate vaccine schedules.
PLoS Med. 2024;21:e1004375. PubMedAbstract available
April 2024
JUNG SM, Loo SL, Howerton E, Contamin L, et al Potential impact of annual vaccination with reformulated COVID-19 vaccines:
Lessons from the US COVID-19 scenario modeling hub.
PLoS Med. 2024;21:e1004387. PubMedAbstract available
March 2024
MOODIE Z, Andersen-Nissen E, Grunenberg N, Dintwe OB, et al Safety and immunogenicity of a subtype C ALVAC-HIV (vCP2438) vaccine prime plus
bivalent subtype C gp120 vaccine boost adjuvanted with MF59 or alum in healthy
adults without HIV (HVTN 107): A phase 1/2a randomized trial.
PLoS Med. 2024;21:e1004360. PubMedAbstract available